| Product Code: ETC9563988 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Sweden continued to rely heavily on imports of raloxifene, with top exporting countries being China, USA, Germany, Switzerland, and the UK. Despite a high concentration of suppliers, the market experienced a declining compound annual growth rate (CAGR) of -7.01% from 2020 to 2024. However, there was a slight uptick in growth from 2023 to 2024, with a growth rate of 5.2%. The market dynamics suggest a need for strategic planning and diversification of sources to mitigate risks associated with over-reliance on a few key suppliers.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Raloxifene Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Raloxifene Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Raloxifene Market - Industry Life Cycle |
3.4 Sweden Raloxifene Market - Porter's Five Forces |
3.5 Sweden Raloxifene Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Sweden Raloxifene Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Sweden Raloxifene Market Revenues & Volume Share, By Demographic, 2021 & 2031F |
3.8 Sweden Raloxifene Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.9 Sweden Raloxifene Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Sweden Raloxifene Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 Sweden Raloxifene Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Sweden Raloxifene Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about osteoporosis and its prevention in Sweden |
4.2.2 Growing elderly population in Sweden, who are more prone to osteoporosis |
4.2.3 Rising demand for effective treatments with fewer side effects |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for pharmaceutical products in Sweden |
4.3.2 Competition from alternative treatment options for osteoporosis |
4.3.3 High cost associated with raloxifene treatment |
5 Sweden Raloxifene Market Trends |
6 Sweden Raloxifene Market, By Types |
6.1 Sweden Raloxifene Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Sweden Raloxifene Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Sweden Raloxifene Market Revenues & Volume, By Antineoplastic, 2021- 2031F |
6.1.4 Sweden Raloxifene Market Revenues & Volume, By Selective Estrogen Receptor Modulators, 2021- 2031F |
6.2 Sweden Raloxifene Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Sweden Raloxifene Market Revenues & Volume, By Osteoporosis, 2021- 2031F |
6.2.3 Sweden Raloxifene Market Revenues & Volume, By Breast Cancer Prevention, 2021- 2031F |
6.3 Sweden Raloxifene Market, By Demographic |
6.3.1 Overview and Analysis |
6.3.2 Sweden Raloxifene Market Revenues & Volume, By Adult, 2021- 2031F |
6.3.3 Sweden Raloxifene Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4 Sweden Raloxifene Market, By Dosage Form |
6.4.1 Overview and Analysis |
6.4.2 Sweden Raloxifene Market Revenues & Volume, By Tablets, 2021- 2031F |
6.4.3 Sweden Raloxifene Market Revenues & Volume, By Capsule, 2021- 2031F |
6.5 Sweden Raloxifene Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Sweden Raloxifene Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 Sweden Raloxifene Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Sweden Raloxifene Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 Sweden Raloxifene Market Revenues & Volume, By Clinic, 2021- 2031F |
6.6.3 Sweden Raloxifene Market Revenues & Volume, By Hospital, 2021- 2031F |
6.7 Sweden Raloxifene Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Sweden Raloxifene Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 Sweden Raloxifene Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.7.4 Sweden Raloxifene Market Revenues & Volume, By , 2021- 2031F |
7 Sweden Raloxifene Market Import-Export Trade Statistics |
7.1 Sweden Raloxifene Market Export to Major Countries |
7.2 Sweden Raloxifene Market Imports from Major Countries |
8 Sweden Raloxifene Market Key Performance Indicators |
8.1 Number of osteoporosis diagnoses in Sweden |
8.2 Prescription rate of raloxifene compared to other osteoporosis treatments |
8.3 Patient adherence rate to raloxifene treatment |
8.4 Number of clinical trials and studies on raloxifene efficacy and safety |
8.5 Patient satisfaction and feedback on raloxifene treatment |
9 Sweden Raloxifene Market - Opportunity Assessment |
9.1 Sweden Raloxifene Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Sweden Raloxifene Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Sweden Raloxifene Market Opportunity Assessment, By Demographic, 2021 & 2031F |
9.4 Sweden Raloxifene Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.5 Sweden Raloxifene Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 Sweden Raloxifene Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 Sweden Raloxifene Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Sweden Raloxifene Market - Competitive Landscape |
10.1 Sweden Raloxifene Market Revenue Share, By Companies, 2024 |
10.2 Sweden Raloxifene Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here